Follow the people · Insider
MPM BioVentures 2014, L.P.
MPM BioVentures 2014, L.P. files insider transactions with the SEC as a 10% owner of Entrada Therapeutics (TRDA). We hold 9 disclosed purchases and sales filed since 29 July 2020, 9 of them in the last 90 days.
- Files forTRDA
- Disclosed buys and sells9 in all, 9 in the last 90 days
- Last disclosure3 September 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 24 August 2026 — 3 September 202610% owner · Entrada Therapeutics (TRDA)9 Form 4 lines · source: SEC Form 4
- Filed 7 November 2025 — 12 November 202510% owner · Werewolf Therapeutics (HOWL)4 Form 4 lines · source: SEC Form 4
- Filed 28 July 2020 — 18 October 202110% owner · iTeos Therapeutics (ITOS)41 Form 4 lines · source: SEC Form 4
Everything they disclosed
54 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 29,088 shares of Entrada TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- ▼ sold on the open market 25,131 shares of Entrada TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 32,263 shares of Entrada TherapeuticsSEC Form 43 September 2026Common Stock · traded 3 September 2026 · filed 3 September 2026
- ▼ sold on the open market 38,922 shares of Entrada TherapeuticsSEC Form 431 August 2026Common Stock · traded 27 August 2026 · filed 31 August 2026
- ▼ sold on the open market 3,733 shares of Entrada TherapeuticsSEC Form 431 August 2026Common Stock · traded 28 August 2026 · filed 31 August 2026
- ▼ sold on the open market 44,259 shares of Entrada TherapeuticsSEC Form 431 August 2026Common Stock · traded 31 August 2026 · filed 31 August 2026
- ▼ sold on the open market 21,623 shares of Entrada TherapeuticsSEC Form 426 August 2026Common Stock · traded 24 August 2026 · filed 26 August 2026
- ▼ sold on the open market 26,522 shares of Entrada TherapeuticsSEC Form 426 August 2026Common Stock · traded 25 August 2026 · filed 26 August 2026
- ▼ sold on the open market 14,569 shares of Entrada TherapeuticsSEC Form 426 August 2026Common Stock · traded 26 August 2026 · filed 26 August 2026
- ▼ sold on the open market 68,480 shares of Werewolf TherapeuticsSEC Form 412 November 2025Common Stock · traded 7 November 2025 · filed 12 November 2025
- ▼ sold on the open market 48,570 shares of Werewolf TherapeuticsSEC Form 412 November 2025Common Stock · traded 10 November 2025 · filed 12 November 2025
- ▼ sold on the open market 55,810 shares of Werewolf TherapeuticsSEC Form 412 November 2025Common Stock · traded 11 November 2025 · filed 12 November 2025
- ▼ sold on the open market 40,669 shares of Werewolf TherapeuticsSEC Form 412 November 2025Common Stock · traded 12 November 2025 · filed 12 November 2025
- ▼ sold on the open market 8,893 shares of iTeos TherapeuticsSEC Form 418 October 2021Common Stock · traded 15 October 2021 · filed 18 October 2021
- ▼ sold on the open market 2,039 shares of iTeos TherapeuticsSEC Form 418 October 2021Common Stock · traded 15 October 2021 · filed 18 October 2021
- ▼ sold on the open market 6,167 shares of iTeos TherapeuticsSEC Form 418 October 2021Common Stock · traded 18 October 2021 · filed 18 October 2021
- ▼ sold on the open market 8,521 shares of iTeos TherapeuticsSEC Form 414 October 2021Common Stock · traded 12 October 2021 · filed 14 October 2021
- ▼ sold on the open market 20,929 shares of iTeos TherapeuticsSEC Form 414 October 2021Common Stock · traded 13 October 2021 · filed 14 October 2021
- ▼ sold on the open market 27,320 shares of iTeos TherapeuticsSEC Form 414 October 2021Common Stock · traded 14 October 2021 · filed 14 October 2021
- ▼ sold on the open market 17,938 shares of iTeos TherapeuticsSEC Form 416 September 2021Common Stock · traded 14 September 2021 · filed 16 September 2021
- ▼ sold on the open market 3,623 shares of iTeos TherapeuticsSEC Form 416 September 2021Common Stock · traded 14 September 2021 · filed 16 September 2021
- ▼ sold on the open market 23,113 shares of iTeos TherapeuticsSEC Form 416 September 2021Common Stock · traded 15 September 2021 · filed 16 September 2021
- ▼ sold on the open market 991 shares of iTeos TherapeuticsSEC Form 416 September 2021Common Stock · traded 15 September 2021 · filed 16 September 2021
- ▼ sold on the open market 119 shares of iTeos TherapeuticsSEC Form 413 April 2021Common Stock · traded 9 April 2021 · filed 13 April 2021
- converted 3,824,591 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 255,094 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 131,645 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 2,415,530 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 128,384 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 47,674 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 2,361,805 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B-2 Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 157,529 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B-2 Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 81,295 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B-2 Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 1,491,666 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B-2 Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 79,281 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B-2 Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 29,440 shares of iTeos Therapeutics (a derivative holding)SEC Form 429 July 2020Series B-2 Preferred Stock · traded 28 July 2020 · filed 29 July 2020
- converted 1,269,230 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 84,655 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 43,687 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 801,619 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 42,605 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 15,820 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 724,702 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 48,336 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 24,944 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 457,706 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 24,326 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- converted 9,033 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- ▲ bought on the open market 89,955 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- ▲ bought on the open market 5,994 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- ▲ bought on the open market 3,096 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- ▲ bought on the open market 56,814 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- ▲ bought on the open market 3,020 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
- ▲ bought on the open market 1,121 shares of iTeos TherapeuticsSEC Form 429 July 2020Common Stock · traded 28 July 2020 · filed 29 July 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.